Listen "Strategies for a successful VIVA, from a former QP Assessor's Perspective ~ Ep11"
Episode Synopsis
In this episode of the QP Diaries podcast, host Dal interviews Mark King, who has over 30 years of experience in Quality based roles within the pharmaceutical industry. Mark is a Qualified Person under the permanent provisions since March 2001, and a former QP Assessor, Vice Chair and Chair of the Royal Society of Biology QP Assessors Panel.During the episode, Mark shares insights from his career journey and offers valuable advice to QPs and trainees. This includes sharing his best tips with trainees preparing for their VIVA, as well as rare insights into his experience as a panel assessor. The discussion also delves into mergers and acquisitions and managing site closures from a QP's perspective, giving important guidance for anyone wishing to further their understanding of the pharmaceutical sector.
Key moments:
[00:01:40] Managing site closures from a QP's perspective.
[00:07:32] Guidance for trainee QPs.
[00:10:21] Practical hands-on experience importance.
[00:13:49] Common reasons for failure.
[00:17:26] Practical experience for successful viva.
[00:19:43] Standout Vivas and Memorable Experiences.
[00:24:14] Importance of patient focus.
[00:26:47] Mergers and acquisitions in pharmaceuticals.
[00:31:39] Business Mergers and Acquisitions.
[00:35:47] Learning from challenging experiences.
[00:39:19] Continuous learning and growth.
[00:41:55] Favorite part of QP role.
[00:43:44] Passion for quality assurance work.
More episodes of the podcast The QP Diaries, by AssureBio
From NHS QP to Innovation Leader – Adam Walker on Aseptic Transformation, AI & GMP Clarity
07/07/2025
Becoming a QP – Navigating Change, VIVA Prep & Real-World Insights with NSF Trainer Vicky
14/04/2025
Championing Quality, Leading with Purpose: Uche Ekwuozor on Diversity and Integrity in Pharma EP 13
02/04/2025
Bitesize Diary Entry - 11 [Mark King]
22/11/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.